Alexandra Bronwen Nelson MD
Movement Disorder
Health Sciences Clinical Instructor, Neurology, UCSF School of Medicine
Join to View Full Profile
Ucsf Neurology Dept 505 Parnassus AveM798 Box 0114San Francisco, CA 94143
Phone+1 415-476-1487
Are you Dr. Nelson?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Summary
- Dr. Alexandra Nelson, MD is a board certified neurologist in San Francisco, California. She is currently licensed to practice medicine in California. She is a Health Sciences Clinical Instructor at UCSF School of Medicine.
Education & Training
University of California (San Francisco)Residency, Neurology, 2006 - 2010- University of California (San Francisco)Internship, Internal Medicine, 2006 - 2007
University of California San Diego School of MedicineClass of 2006
Certifications & Licensure
CA State Medical License 2008 - 2026
American Board of Psychiatry and Neurology Neurology
Publications & Presentations
PubMed
- 1 citationsChronic hyperactivation of midbrain dopamine neurons causes preferential dopamine neuron degeneration.Katerina Rademacher, Zak Doric, Dominik Haddad, Aphroditi Mamaligas, Szu-Chi Liao
Biorxiv. 2025-03-04 - 1 citationsInhibition of Indirect Pathway Activity Causes Abnormal Decision-Making In a Mouse Model of Impulse Control Disorder in Parkinson's Disease.Xiaowen Zhuang, Julia Lemak, Sadhana Sridhar, Alexandra B Nelson
Biorxiv. 2024-11-01 - Striatal lateral inhibition regulates action selection in a mouse model of levodopa-induced dyskinesia.Emily L Twedell, Chloe J Bair-Marshall, Allison E Girasole, Lara K Scaria, Sadhana Sridhar
Biorxiv. 2024-11-01
Press Mentions
Opinion: An Open Letter to BUSD — Open Schools as Soon as PossibleFebruary 10th, 2021
UCSF Weill Institute for Neurosciences Announces Innovation, Scholar AwardsOctober 27th, 2016
Parkinson's Disease Foundation Announces $4 Million in Research Investments to Solve, Treat and End Parkinson's DiseaseJune 9th, 2016
